Related Experiment Videos

Indications for BCG use in carcinoma in situ

¹Department of Urology, Kaiser Hospital, Kaiser Medical Group, Los Angeles, California.

|January 1, 1991

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Bacillus Calmette-Guérin immunotherapy. Techniques and results.

The Urologic clinics of North America·1992

Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

The Journal of urology·1992

Transrectal ultrasound-guided interstitial radiation therapy for localized prostate cancer.

Urology·1991

The preparation, handling and use of intravesical bacillus Calmette-Guerin for the management of stage Ta, T1, carcinoma in situ and transitional cell cancer.

The Journal of urology·1990

A practical guide to the use of intravesical BCG for the management of stage Ta, T1, CIS, transitional cell cancer.

Progress in clinical and biological research·1989

Ras related oncogene protein as a tumor marker in transitional cell carcinoma of the bladder.

The Journal of urology·1987

See all related articles